Quick Facts

Burning Rock Biotech Q1 Loss Narrows, But Revenue Drops

Burning Rock Biotech Limited (BNR) Wednesday reported loss before tax of RMB121.37 million or $16.81 million for the first quarter, lesser than RMB184.83 million loss in the same quarter a year ago, primarily due to reduced operating expenses.

Operating expenses in the first quarter decreased to RMB211.52 million from RMB287.23 million last year.

Net loss narrowed to RMB121.55 million or $16.84 million from RMB185.25 million loss a year ago. Net loss per share was RMB1.19 or $0.16, compared with RMB1.81 loss a year ago.

Revenue for the quarter declined 11.9 percent to RMB125.62 million or $17.4 million from RMB142.52 million in the previous year.

Looking ahead, the company said it expects to achieve breakeven for the full year.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

More Quick Facts